Pain Management Treatment Market to Catapult by 2018

Pain Management Treatment Market to Catapult by 2018

ID: 238109

(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/11/13 -- TriMarkPublications.com cites in its newly published " Treatment Markets" report that the treatment market will catapult by 2018. For more information, visit: .

drugs, or analgesics, can be categorized into three main modalities: acetaminophen, NSAIDs and opioids. Pain, meanwhile, can be categorized into four main modalities: acute, chronic, neuropathic and nociceptive. The market is currently valued at $52 billion. Growing at a rate of 20%, the opioid segment will constitute a full 43% of the market by 2018. Although the U.S. market will only increase modestly to $21.8 billion, it remains the largest market by far throughout the forecast period.

The " Treatment Markets" report covers:

CGRP antagonists

CB2 agonists

Sodium channel modulators

Calcium channel modulators

NMDA antagonists

P2x receptors

Trp channels

TrpV1 blockers

FAAH inhibitors

Novel opioids

Extended release formulations

Transdermal formulations

The " Treatment Markets" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Abbott, AcelRx, Acura, Afferent, Algiax, Arcion, Astellas, BioDelivery Sciences, Cara, Cephalon, Convergence, Cytogel, DURECT, Egalet, Eli Lilly, Endo, Grünenthal, Hospira, iMed, Johnson & Johnson, KemPharm, Mallinckrodt, NeurAxon, NeurogesX, Newron, Novartis, Nuvo, Pacira, Pain Therapeutics, Pfizer, Purdue, QRx, Relevare, Relmada, Spinifex, Xenon, Xenoport, Zalicus and Zogenix.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .



TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .



The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.









TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  National Business Group on Health Honors Aetna, Highmark, Prudential Financial With Awards for Reducing Health Care Disparities EnteroMedics to Present at 25th Annual Roth Capital Partners Conference
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 11.03.2013 - 17:00 Uhr
Sprache: Deutsch
News-ID 238109
Anzahl Zeichen: 0

contact information:
Town:

NEW YORK, NY



Kategorie:

Health & Nutrition



Diese Pressemitteilung wurde bisher 258 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Pain Management Treatment Market to Catapult by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von

TriMarkPublications.com (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von TriMarkPublications.com



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z